KATE SNIDER: Open Payments
NPI 1548849243 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 52 payments from 16 companies in 2025. Trend: 2023 $627 · 2024 $876 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $239 |
| PFIZER INC. | 10 | $200 |
| Novo Nordisk Inc | 6 | $108 |
| ABIOMED | 2 | $67 |
| Esperion Therapeutics, Inc. | 3 | $64 |
| Amgen Inc. | 3 | $49 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boston Scientific Corporation | 2 | $31 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| Edwards Lifesciences Corporation | 1 | $21 |
Products named: LEQVIO, VYNDAQEL, Wegovy, NEXLETOL, REPATHA, VERQUVO, WATCHMAN FLX, Attruby.
Industry payments across OH — which companies pay providers there.
